LEADER 02490nam 2200553 450 001 9910826687403321 005 20230801230850.0 010 $a1-78084-165-5 035 $a(CKB)2670000000391286 035 $a(EBL)1179616 035 $a(OCoLC)851970655 035 $a(SSID)ssj0001524401 035 $a(PQKBManifestationID)11851187 035 $a(PQKBTitleCode)TC0001524401 035 $a(PQKBWorkID)11476167 035 $a(PQKB)11456300 035 $a(MiAaPQ)EBC1179616 035 $a(Au-PeEL)EBL1179616 035 $a(EXLCZ)992670000000391286 100 $a20220517d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAddressing unmet needs in osteoarthritis /$feditors, Johanne Martel-Pelletier, Jean-Pierre Pelletier 205 $a1st ed. 210 1$aLondon :$cFuture Medicine Ltd.,$d[2012] 210 4$dİ2012 215 $a1 online resource (162 p.) 300 $aDescription based upon print version of record. 311 $a1-78084-167-1 327 $aTitle page; Copyright page; Contents; Foreword. Addressing unmet needs in osteoarthritis; 1. Definition,classification andrisk factors; 2. Signs, symptoms and diagnosis of clinical osteoarthritis; 3. Genetics and clinical applications; 4. Use of biomarkers for the purposes of diagnosis and drug discovery programs: where do we stand?; 5. New drugs in clinical trials for osteoarthritis; 6. Surgical approaches for treatment of osteoarthritis; 7. Nonpharmacological modalities, nutraceuticals and dietary supplements as therapies; 8. Management algorithm 327 $a9. Clinical practice guidelines for osteoarthritis10. Clinical benchmarking; Index 330 $aOsteoarthritis, the most prevalent form of arthritis, is a leading cause of chronic disability worldwide and a major public health issue. Here, internationally renowned authors, from multiple specialties, analyze, dissect and provide a comprehensive update on this disease. 606 $aOsteoarthritis$xDiagnosis 606 $aOsteoarthritis$xTreatment 615 0$aOsteoarthritis$xDiagnosis. 615 0$aOsteoarthritis$xTreatment. 676 $a616.7223075 702 $aMartel-Pelletier$b Johanne 702 $aPelletier$b Jean$f1952- 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910826687403321 996 $aAddressing unmet needs in osteoarthritis$94081389 997 $aUNINA